Product Information
LEVOTHYROXINE 100 MCG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0507 per EA under NDC 00480870110. Its NADAC has been published 202 times since Oct 26, 2022.
FDA first approved this application on May 10, 2022. Its Orange Book therapeutic-equivalence code is AB1,AB2,AB3,AB4 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 ug/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480870110
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA207588FDA Approved
5/10/2022
TE Code
AB1,AB2,AB3,AB4
On Market Since
9/21/2022
Pharmacological Classes
Price Statistics
The NADAC for LEVOTHYROXINE 100 MCG TABLET has been published 202 times since Oct 26, 2022, and over the history we have for it it has declined 58.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0507 per EA |
|---|---|
| All-time high | $0.1251 (Dec 14, 2022) |
| All-time low | $0.0403 (May 22, 2024) |
| 52-week high | $0.0580 |
| 52-week low | $0.0507 |
| Median price | $0.0585 |
| Average price | $0.0693 |
| Largest weekly change | +54.1% (Jun 19, 2024) |
| Weeks tracked | 202 |
| Tracking since | Oct 26, 2022 |
1W
N/A
1M
N/A
3M
-0.4%
6M
-3.5%
1Y
-7.7%
3Y
-32.8%
5Y
N/A
All
-58.1%
Last surveyed Sep 2, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levothyroxine sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
l-Thyroxine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVOTHYROXINE 100 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVOTHYROXINE 100 MCG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0507 per EA (NDC 00480870110), effective Sep 2, 2026.
How has the price of LEVOTHYROXINE 100 MCG TABLET changed over time?
Over the history we have for it, the NADAC for LEVOTHYROXINE 100 MCG TABLET has declined 58.1%. It has been tracked across 202 weekly CMS publications since Oct 26, 2022.
What are the highest and lowest recorded NADAC prices for LEVOTHYROXINE 100 MCG TABLET?
Since Oct 26, 2022, the NADAC for LEVOTHYROXINE 100 MCG TABLET has ranged from a low of $0.0403 (May 22, 2024) to a high of $0.1251 (Dec 14, 2022), with a median of $0.0585 per EA.
Are there cheaper alternatives to LEVOTHYROXINE 100 MCG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LEVOTHYROXINE 100 MCG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LEVOTHYROXINE 100 MCG TABLET?
LEVOTHYROXINE 100 MCG TABLET (NDC 00480870110) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.